Creative Medical Technology (CELZ) to Release Quarterly Earnings on Friday

Creative Medical Technology (NASDAQ:CELZ) will likely be announcing its earnings results before the market opens on Friday, March 28th. Analysts expect the company to announce earnings of ($0.63) per share for the quarter.

Creative Medical Technology Trading Up 0.5 %

Shares of NASDAQ:CELZ opened at $2.21 on Thursday. The company has a 50 day moving average of $3.78 and a 200-day moving average of $3.24. The firm has a market cap of $3.86 million, a P/E ratio of -0.58 and a beta of 1.70. Creative Medical Technology has a twelve month low of $1.92 and a twelve month high of $6.90.

About Creative Medical Technology

Creative Medical Technology Holdings, Inc, a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease.